There are provocative proposals with more liberal criteria in terms of the higher tumor burden allowed but conditioning the inclusion on the waiting list to patients with low serum alpha-fetoprotein levels, the absence of moderate-poor tumor differentiation in the biopsy, or to patients with successful downstaging to the Milan criteria using locoregional therapies [23]. Here, AFP is linked to neoplasm.